Latest Breaking News On - Black diamond therapeutics - Page 1 : comparemela.com

Bellevue Group AG Has $23 99 Million Position in Black Diamond Therapeutics, Inc (NASDAQ:BDTX)

Bellevue Group AG grew its holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 8,535,839 shares of the company’s stock after buying an additional 400,000 shares during the quarter. Bellevue […]

Bellevue groupCitigroup incJump financialCornercap investment counsel incAlgert globalDiamond therapeutics incBlack diamond therapeuticsFree reportFire capitalCornercap investment counselDiamond therapeuticsGet free reportBlack diamond therapeutics daily

Black Diamond Therapeutics : Reports First Quarter 2024 Financial Results and Provides Corporate Update - Form 8-K

Black Diamond Therapeutics : Reports First Quarter 2024 Financial Results and Provides Corporate Update - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomShannon campbellPrakash ramanWendy dixonMario corsoMark vellecaAlex maywegCompany masterkeyIvy brain tumor centerDiamond therapeutics incGuardant healthExchange commissionFoundation medicine foundationinsightsDevelopment expensesAmerican association for cancer research

Cognition Therapeutics (NASDAQ:CGTX) versus Black Diamond Therapeutics (NASDAQ:BDTX) Financial Comparison

Cognition Therapeutics (NASDAQ:CGTX) versus Black Diamond Therapeutics (NASDAQ:BDTX) Financial Comparison
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomCognition therapeutics incTherapeutics incDiamond therapeutics incCognition therapeuticsGet free reportBlack diamond therapeuticsBlack diamond therapeuticDiamond therapeuticsGiven cognition therapeuticBlack diamondCognition therapeutics daily

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPatrick wenMario corsoYoshie umemuraIvy brain tumor centerDana farber cancer instituteDiamond therapeutics incHarvard medical schoolExchange commissionAmerican society of clinical oncologyCompany masterkeyBarrow neurological instituteDiamond therapeutics announces presentationsClinical oncologyDiamond therapeutics

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

CAMBRIDGE, Mass., April 24, 2024 Black Diamond Therapeutics, Inc. , a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with.

United kingdomUnited statesYoshie umemuraPatrick wenMario corsoBarrow neurological instituteDana farber cancer instituteHarvard medical schoolIvy brain tumor centerCompany masterkeyDiamond therapeutics incExchange commissionDiamond therapeuticsInvestigator sponsored trialGeneration covalentRecurrent glioblastoma